Skip to main content
FNIH Logo
FNIH Logo
Home

Main navigation

  • Our Value
    • Advancing Biomedical Innovation
    • Why Our Work Matters
    • Our Promise
  • Our Programs
    • All Programs
    • Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
    • Accelerating Medicines Partnership® Program (AMP)
    • Awards, Prizes, and Events
    • Biomarkers Consortium
    • GeneConvene Global Collaborative
  • Our People
    • Board of Directors and Governance
    • Staff
  • Let's Collaborate
    • Advancing Research
    • Advancing Scientists
    • Advancing Our Shared Mission

Utility

  • News
    • Press Releases
    • Announcements
    • Digital Timeline
  • Careers
  • Donate

Breadcrumb

  1. Home
  2. All Programs

All Programs

Refine Results View All Programs

Refine Results

Popular
Program Type
Topic Area
Project Status
Government Entities
  • Research
  • Lectures, Awards and Events
  • Neurodegenerative Disorder
  • Musculoskeletal Disorders
  • Neurodevelopmental Disorders
  • Osteoporosis
  • Aging x
  • Arthritis x
  • Active Projects
  • In Fundraising
  • Completed Projects x
  • Food and Drug Administration
  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • National Cancer Institute (NCI)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institute of Mental Health (NIMH)
  • National Institutes of Health (NIH)
  • National Institute on Aging (NIA) x
8 Results
Lectures, Awards and Events

2019 NIH GSIG Geroscience Summit

Research

Osteoarthritis Initiative

Lectures, Awards and Events

Go4Life

Research

Plasticity and Mechanisms of Cognitive Remediation in Older Adults

Lectures, Awards and Events

Cognitive Aging Summit III

Research

Biomarkers Consortium – Sarcopenia as a Valid Biomarker for Identifying Individuals at Risk of Disability

Research

Biomarkers Consortium - Osteoarthritis Biomarkers Project

Research

Biomarkers Consortium - Establish Guidelines for Initial Diagnostic Criteria for “Sarcopenia with Clinically Important Weakness” and Associated Evidence for Treatment Benefit

Follow Us

  • Facebook
  • Twitter
  • Youtube
  • LinkedIn

Footer

  • Privacy Policy
  • Terms of Use
  • State Nonprofit Disclosures
  • NIH
  • Financials & Annual Reports
  • Equity, Diversity and Inclusion
  • Contact

Four Stars from Charity Navigator